[
    [
        {
            "time": "2023-10-01",
            "original_text": "This 5% Dividend Yield Isn't Good Enough for Me",
            "features": {
                "keywords": [
                    "Dividend Yield",
                    "5%",
                    "Isn't Good Enough"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "This 5% Dividend Yield Isn't Good Enough for Me",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Glaxo's Shingles Vaccine Shingrix Gets Approval in China",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Shingles Vaccine",
                    "Shingrix",
                    "Approval",
                    "China"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Glaxo's Shingles Vaccine Shingrix Gets Approval in China",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]